Wolfgang Miesbach: An Important Topic on How Care for Bleeding Disorders Can Be Organized Across Europe at EAHAD 2026
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
”In Dublin at EAHAD2026, an important topic was not a new drug – but how care for people with bleeding disorders can be organized across Europe.
The EAHAD–EHC accreditation model for European Haemophilia Centres lead by Ana Boban and Fariba Baghaei evolving to:
- Reflect novel therapies and gene therapy within updated centre
- Define clear roles for Comprehensive Care Centres (EHCCC) and Treating Centres (EHTC) in a hub‑and‑spoke
- Introduce structured on‑site and online audits as a permanent part of the accreditation processe
A pilot audit project across several centres tested the feasibility of combining remote and on‑site assessments and showed that audits can be used as a quality‑improvement tool, not just a regulatory exercise.
For patients and families, the EHCCC/EHTC designation means a minimum guaranteed level of multidisciplinary expertise, laboratory support and 24/7 emergency access, wherever they live.”

More from EAHAD 2026 featured in Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026